Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer
Status:
Not yet recruiting
Trial end date:
2024-10-31
Target enrollment:
Participant gender:
Summary
To evaluates the effectiveness and safety of Surufatinib combined with chemotherapy plus
Toripalimab or not for the first-line treatment of SCLC, and maintenance therapy are
Surufatinib combined with Toripalimab or not.